Nitinol Medical Devices Market to Become Worth US$ 25,657.5 Mn by 2026

Global Nitinol Medical Devices Market: Snapshot

In a consolidated yet competitive global nitinol medical devices market, savvy players are hard-focused on product innovation to strengthen their position. Keen players are also vying to expand their geographical outreach by means of strategic partnerships and mergers and acquisitions.

Majorly fuelling the global nitinol medical devices market is the rising prevalence of cardiovascular diseases, growing geriatric population susceptible to peripheral artery diseases, and increasing demand for minimally invasive surgical procedures. As per statistics of the World Health Organization, almost 17.7 million individuals suffer from cardiovascular diseases each year; cardiovascular diseases account for 31% deaths each year globally.

As per estimates of a report by Transparency Market Research (TMR), the global nitinol medical devices market will be valued at US$25,657.5 mn by the end of 2025 vis-à-vis revenue from US$12,783.9 mn in 2016 at a CAGR of 8.2% therein.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1685

Hospitals End-use Segment to Continue to Lead through 2025

Depending upon product type, the global nitinol medical devices market is classified as nitinol stents, nitinol guidewires, nitinol filters, nitinol basket, nitinol catheters, and others (needles, staples, sheath, pins, and wires, etc.). Nitinol guidewires is further segmented into orthodontic guidewires and endoscopic guidewires.

Amongst all, nitinol stents segment led the overall market in terms of revenue in 2016; going forward the segment is anticipated to further grow due to increasing prevalence of cardiovascular diseases and peripheral vascular diseases. The growth of nitinol stents segment is mainly because of high efficacy of nitinol-based coronary and peripheral stents in the treatment of cardiovascular diseases. As per Diagnostic & Interventional Cardiology, prevalence of percutaneous coronary intervention (PCI) procedures in the U.S. is four times as compared to coronary artery bypass graft (CABG) procedures.

Based on application, the key segments include orthopedic, vascular, dental, gastroenterology, and others. The vascular segment held the leading market share of more than 60% in 2016 in the global nitinol medical devices market. This is mainly because of rising prevalence of cardiovascular diseases and increasing adoption of nitinol based stents for vascular surgeries.

Based on end-user, the report classifies the global nitinol medical devices market into hospitals, clinics, ambulatory surgical centers, and others. In 2016, hospitals led the market and the trend is anticipated to continue over the forecast period. The growth of hospitals segment is attributed to the increasing demand for minimally invasive surgeries and increasing number of surgeries for vascular and orthopedic diseases. However, clinics and ambulatory surgical centers segments are anticipated to surpass in terms of growth rate over the forecast period due to surging demand for same-day surgeries.

High Prevalence of Peripheral Artery Disease among Geriatrics Makes North America Leader

Based on region, the nitinol medical devices market has been classified into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. North America accounted for the leading market share vis-à-vis revenue in 2016 due to increasing adoption of technologically advanced products and increasing prevalence of peripheral artery disease. As per statistics of the Houston Methodist Research Institute, peripheral arterial disease affects 13% to14% of the elderly population in the U.S. Further, prevalence of peripheral artery disease, which increases with age, can also range from 13% to 32% among individuals of 80 years of age.

Powered by the U.K, Germany, and France Europe is a key market for nitinol medical devices. As per the European Heart Network, cardiovascular diseases are responsible for 3.9 million deaths each year in Europe. In 2015, 11.3 million new cases of cardiovascular diseases were reported in Europe.

Prominent names in the global nitinol medical devices market include B.Braun Melsungen AG, C.R. Bard Inc., Arthrex Inc., Zimmer Biomet Holdings Inc., Cook Medical, Medtronic, W.L. Gore & Associates Inc., Terumo Corporation, Abbott Laboratories, Boston Scientific Corporation, and Endosmart GmbH.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Transparency Market Research Report Added "Lateral Flow Assay Market" to its database.